NMRA approves emergency use of 'Sputnik V' vaccine | Daily News

NMRA approves emergency use of 'Sputnik V' vaccine

The National Medicines Regulatory Authority (NMRA) of Sri Lanka has approved the use of the COVID-19 vaccine ‘Sputnik V’, manufactured by Russia, Acting Health Minister and State Minister of Pharmaceuticals Supply and Production Prof Channa Jayasumana said.

Speaking to the media, Prof Jayasumana said that the Expert Committee of the NMRA had approved the vaccine for emergency use in Sri Lanka.

Sputnik V is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology and it was registered on August 11 last year by the Russian Ministry of Health.